Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Axovant trumpets new clinical data after gene therapy pivot
Fierce Biotech
Mon, 03/11/19 - 10:11 pm
Axovant
gene therapy
Parkinson's Disease
Tay Sachs
[video+transcript]Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?
Motley Fool
Sat, 03/9/19 - 12:11 pm
gene therapy
M&A
Rengexbio
Biogen to acquire ophthalmology gene therapy play Nightstar
BioCentury
Mon, 03/4/19 - 10:37 am
Biogen
M&A
Nightstar Therapeutics
gene therapy
ophthalmology
After J&J retinal deal, MeiraGTx raises $80M for unpartnered programs
BioCentury
Wed, 02/27/19 - 07:16 pm
MeiraGTx
JNJ Innovation
gene therapy
retinal disease
Gene Therapy Market Heats up as Sarepta Buys Myonexus for $165 Million
BioSpace
Wed, 02/27/19 - 10:57 am
Sarepta Therapeutics
gene therapy
M&A
Myonexus
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy
Xconomy
Mon, 02/25/19 - 10:00 am
Roche
gene therapy
Spark Therapeutics
M&A
Voyager Shares Take Off on Parkinson's Disease Development Deal
TheStreet.com
Fri, 02/22/19 - 10:11 am
Voyager Therapeutics
gene therapy
AbbVie
Parkinson's Disease
Neurogene Launches With $68.5 Million to Advance Gene Therapies for Rare Neurological Diseases
BioSpace
Tue, 02/12/19 - 12:07 pm
Neurogene
gene therapy
neurological disorders
J&J snags rights to a gene therapy portfolio from little MeiraGTx, a spinoff from Sam Waksal’s Kadmon
Endpoints
Thu, 01/31/19 - 11:46 am
JNJ
MeiraGTx
gene therapy
Novartis: Alternative payments will ‘reset the paradigm’ for covering gene, cell therapies
Fierce Pharma
Tue, 01/29/19 - 07:21 pm
Novartis
ICER
spinal muscular atrophy
alternative payments
drug pricing
gene therapy
Zolgensma
Neurocrine Pays $165M to Bankroll Voyager’s Gene Therapy for Parkinson’s
Xconomy
Tue, 01/29/19 - 09:59 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
VY-AADC
gene therapy
Moment of truth for Sarepta and Myonexus
EP Vantage
Wed, 01/23/19 - 07:49 pm
Sarepta Therapeutics
gene therapy
MYO-101
Limb Girdle Muscular Dystrophy
Gottlieb, Marks detail plans to advance development of cell and gene therapies
Endpoints
Wed, 01/16/19 - 10:05 am
FDA
Scott Gottlieb
CBER
cell therapy
gene therapy
Massachusetts Initiative Looks at Payment Plans for Novartis' SMA Gene Therapy
BioSpace
Mon, 01/14/19 - 11:55 pm
Massachusetts
Novartis
SMA
gene therapy
Kymriah
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy
Yahoo/Reuters
Sat, 01/12/19 - 08:49 pm
Eli Lilly
Loxo Oncology
M&A
CAR-T
gene therapy
JPM19: Spark looks at scale, manufacturing as gene therapy matures
Biopharma Dive
Thu, 01/10/19 - 08:45 pm
JPMHC 2019
Spark Therapeutics
gene therapy
Luxturna
Ex-Juno execs launch cell therapy start-up Sana
BioCentury
Sat, 01/5/19 - 12:07 am
Sana Biotechnology
R&D
cell therapy
gene therapy
Juno Therapeutics
Sarepta inks deal to bolster gene therapy manufacturing
Biopharma Dive
Fri, 01/4/19 - 09:06 am
Sarepta Therapeutics
Aldevron
gene therapy
Orphan Drug Designation Granted to Investigational Gene Therapy for Rare Form of Muscular Dystrophy
CP Wire
Wed, 01/2/19 - 10:08 am
Limb Girdle Muscular Dystrophy
muscular dystrophy
FDA
Myonexus
NYO-102
gene therapy
Biogen backs away from AGTC after gene therapy failure
BioPharma Dive
Thu, 12/13/18 - 09:10 pm
gene therapy
Biogen
Applied Genetic Technologies
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »